Abstract

Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 18, 2010
  • Application: Jan 1, 2008
    US US 96817808 A
  • Priority: Jan 1, 2008
    US US 96817808 A
  • Priority: Nov 5, 2004
    US US 98214504 A
  • Priority: May 6, 2003
    US US 0314106 W
  • Priority: May 6, 2002
    US US 14164502 A
  • Priority: Apr 18, 2002
    US US 0212353 W
  • Priority: Apr 18, 2001
    US US 28485501 P

Sign in to the Lens